Haemophilia: Medical Treatments
(asked on 29th October 2018) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to Trigger 1 of NHS England’s Specialised Commissioning Briefing (Spring 2018), how the faster adoption of best value medicines requirement will affect the procurement of Extended Half Life factor VIII products; and which Factor VIII blood products will be covered by the Commissioning for Quality and Innovation.
This question was answered on 6th November 2018
I refer the hon. Member to the answer I gave on 4 September 2018 to Question 167279.